Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of Oral Dexpramipexole in Eosinophilic Asthma

businesswire

Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of Oral Dexpramipexole in Eosinophilic Asthma – NEWSnet – News… as it used to be

More Press Releases

June 10, 2026

JETOUR’s Return of the Cheetah: Horn of Africa Wins Telly Awards

June 10, 2026

HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit

June 10, 2026

Lithosphere Expands Investor Access Through LITHO Deals Platform Ahead of Planned TGE

June 10, 2026

Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of Oral Dexpramipexole in Eosinophilic Asthma

JETOUR’s Return of the Cheetah: Horn of Africa Wins Telly Awards

HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit

Lithosphere Expands Investor Access Through LITHO Deals Platform Ahead of Planned TGE

X Square Robot Open-Sources XRZero-G0 to Scale Robot Learning with Interfaces, Data Quality and Ratios